|
Medical Device Safety
|
|
|
|||
Potential Problems with Insulin Pens in Hospitals | |||
In a recent article, the Institute for Safe Medication Practices (ISMP) highlighted several potential safety problems when hospitals switch from multiple dose vials of insulin to insulin pens. ISMP points out that there are certain safety advantages in using the pens. For example, the pens may reduce the chance of drug mix-ups, since each pen is pre-labeled with product name and strength, and the patient's name can be on the label as well. But ISMP also notes a number of potential safety problems to watch out for when hospitals switch to pens... | |||
Serious Complications from Using Recombinant Bone Morphogenetic Protein in the Cervical Spine | |||
FDA is alerting healthcare professionals about reports of life-threatening complications from the use of recombinant human Bone Morphogenetic Protein (rhBMP) in cervical spine fusion. Although FDA has approved two rhBMP products for very specific medical conditions, the safety and effectiveness of rhBMP in the cervical spine have not been demonstrated, and FDA has not approved it for this use.... |
Updated October 2, 2008
CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page
Center for Devices and Radiological Health / CDRH